Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Prochlorperazine is a dopamine D2 receptor antagonist with Ki values of 4.7 and 2.9 nM for rat recombinant D2 receptors in CHO cells and rat striatal membranes, respectively.1,2 It also binds to rat recombinant D3 receptors expressed in CHO cells (Ki = 35 nM) and to the serotonin (5-HT) receptor subtype 5-HT3 in N1E-115 mouse neuroblastoma cell membranes (Ki = 1,200 nM).1,3 Prochlorperazine (2 mg/kg) increases the latency to paw licking in a hot plate test, indicating analgesia, an effect that is blocked by antisense oligonucleotides against the M1 muscarinic receptor.4 It also inhibits emesis induced by apomorphine (Item No. 16094) in dogs (ED50 = 0.34 mg/kg).5 Formulations containing prochlorperazine have been used in the treatment of psychotic disorders and as antiemetics.
WARNING This product is not for human or veterinary use.
1. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 137(6289), 146-151 (1990).
2. Binding of [3H]haloperidol to dopamine D2 receptors in the rat striatum. J. Pharm. Pharmacol. 44(11), 911-914 (1992).
3. Radioligand binding and photoaffinity labelling studies show a direct interaction of phenothiazines at 5-
4. Prochlorperazine induces central antinociception mediated by the muscarinic system. Pharmacol. Res. 50(3), 351-358 (2004).
5. Antiemetic specificity of dopamine antagonists. Psychopharmacology (Berl.) 78(3), 210-213 (1982).